Economic policy uncertainty and corporate innovation-empirical evidence from Chinese pharmaceutical listed companies

Economic policy uncertainty and corporate innovation-empirical evidence from Chinese pharmaceutical listed companies

IntroductionUnder the background that economic policy uncertainty tends to be normal, the innovation behavior of enterprises can cope with the cost impact brought by economic policy uncertainty.MethodsBased on the relevant data of China’s A-share pharmaceutical listed companies from 2015 to 2022, th...

Full description

Saved in:
Bibliographic Details
Main Authors: Zikun Wu, Su Wang, Licong Kuang, Yuwen Chen
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-12-01
Series:Frontiers in Public Health
Subjects:
economic policy uncertainty
corporate innovation
financialization
listed pharmaceutical companies
cost
Online Access:https://www.frontiersin.org/articles/10.3389/fpubh.2024.1411495/full
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items